Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

 Marketing

Novartis: lawsuits, layoffs and, by the way, earnings

April 24, 2013

It was an all-in-one news day for the drug maker which, by the way, saw sales rise 2% for the first quarter, compared to the same period last year.
 

Success in emerging markets hinges on broad network

April 03, 2013

Execs told Booz & Co researchers that the relationships web in emerging markets needs to be deeper than one-on-one sales pitches.
 

Social media guru Gwee joins Chandler Chicco

April 02, 2013

Gwee, who pioneered pharma social media at Vertex before moving onto the agency side, is tasked with integrating digital and social strategies across the marketing and PR network's 14 agencies.
 

Why SGLT-2s may put some spring into pharma spending

Jerry Maynor March 28, 2013

Should the FDA give the thumbs-up to J&J diabetes pill Invokana tomorrow, expect a blockbuster US marketing push, says CSD's Jerry Maynor.
 

Note to sales: don't panic when reading these numbers

March 28, 2013

At first blush, Accenture's survey of pharma execs looks like more bad news for sales forces, but the firm tells MM&M that the sales overhauls are about more than reducing headcounts.
 

IMS Health gobbles up SaaS firm Appature

March 12, 2013

IMS Health has acquired Seattle-based software-as-a-service (SaaS) company Appature, the firms are expected to announce today.
 

Business briefs: Lundbeck, FDA, Tower Watson and National Business Group Study, Merck

March 07, 2013

Lundbeck and Otsuka deepen their Abilify co-promotion partnership; study finds FDA clinical trial rule isn't sticking; another study confirms that employees are paying more for health insurance as employers pay less; Merck appoints new R&D chief
 

Gift study shows med students still being comped

March 07, 2013

Gift bans or no, students still connect with drug companies, a study has found.
 

Docs to pharma marketers: you're not getting it

March 07, 2013

An ePharma Summit panel of physicians takes the sheen off new marketing initiatives by telling pharmas they find them useless.
 

Business briefs: Gilead, Shire, The Medicines Co., HHS

February 04, 2013

HHS wants input for its TXT4Tots childhood advice program, Gilead releases some Hep. C clinical trial data, and Shire settles with the DOJ over disputed marketing practices.
 

Researchers find schools minting pitch-resistant docs

February 04, 2013

A BMJ study finds that medical school gift bans make doctors less likely to prescribe a new drug. Also of note: consumers think money motivates some doctors' recommendations.
 

Santarus loads up on sales reps

January 29, 2013

The company is beefing up its marketing staff, using an iPad-equipped mix of in-house and contracted talent.
 

Orexigen rethinks clinical trial recruitment

January 24, 2013

Orexigen slashed its clinical trial recruitment period by 14 months using marketing tactics associated with retail.
 

Study says color and shape linked to Rx adherence

January 03, 2013

A study on the effect that a medication's color and shape have on adherence gives short shrift to the marketing component that urges patients not to take medications that don't conform to doctors' orders
 

Transcept, Purdue plan DTC effort to revive sleep-drug launch

November 27, 2012

Facing lower-than-expected demand, Purdue and Transcept are broadening the commercial strategy for Intermezzo to include DTC and a larger selling force.
 

Mylan expands Epi-Pen strategy

September 27, 2012

Emmy-winner Julie Bowen is part of the effort to spread allergy education and awareness in schools.
 

Search doubles as health narrative, Google finds

September 25, 2012

Google's latest data shows that the doctor-patient information divide isn't so much a divide as two parts of the same conversation.
 

Company news: Elsevier, Abbott, Genzyme

August 22, 2012

Elsevier launches new drug class overviews, a whistleblower accuses Abbott and Genzyme clears the way for Lemtrada.
 

KV files for bankruptcy, lists FDA among woes

August 06, 2012

Following warnings that the worst might be coming, KV said Monday it will seek Chapter 11 bankruptcy protection.
 

Petition asks FDA to set opioid marketing ground rules

July 26, 2012

The proposed changes center around non-cancer related pain and seek to alter how drug companies can talk about these pain meds.
 

Shire rebranding part of larger push into regenerative med

July 23, 2012

Shire says the field of regenerative medicine is about to take off, and is building on the expertise acquired with Advanced BioHealing.
 

Novartis boasts strong new drug sales, streamlined marketing spend in Q2 earnings

July 19, 2012

Novartis continued to shrink its marketing spend in the second quarter, and Excedrin woes will continue until the fourth quarter, the company said in its Q2 earnings report
 

Merck's Claritin campaign under fire

June 21, 2012

An advocacy group wants Merck to back away from a recent Children's Claritin promotion, and has brought the FTC in as a referee. The issue: a marketing tactic that incorporates the characters from the DreamWorks's animated Madagascar trilogy.
 

GSK hopes $3-bil. off-label settlement will end legal woes

November 07, 2011

GlaxoSmithKline's deal to resolve multiple US investigations into its sales and marketing practices—one of the largest settlements by a pharma company—aims to patch up several long-running legal disputes.
 

Pfizer's post-expiry plan for Lipitor: maximize brand's sales

November 02, 2011

Pfizer said it plans not only to keep Lipitor consumer promotions running past the brand's expiry later this month. It also aims to put an OTC version of the megablockbuster on the market at some point.
 

Feds subpoena Merck on marketing of hepatitis, cancer drugs

August 08, 2011

Merck said it received a subpoena related to marketing and selling activities with respect to three drugs: Temodar, PegIntron and Intron A.
 

Pain drug monitoring firm enticed docs to use test, qui-tam suit charges

July 06, 2011

A national lab promised doctors they could enrich themselves by as much as $2 million a year through a scheme that involved billing payers multiple times for the same urinary drug test, a whistleblower suit alleges.
 

Off-label marketing offenses cost Elan $203 million

March 01, 2011

Elan Pharmaceuticals pleaded guilty today to a misdemeanor violation for illegally promoting epilepsy drug Zonegran.
 

In Coumadin banter, lessons for marketers of new blood thinners

October 27, 2010

A love-hate relationship for Coumadin (warfarin) is playing out online, say authors of a new report that may offer lessons for marketers of new blood-thinning products.
 

Novartis held the line on sales and marketing spend in 2009

January 26, 2010

Novartis' US sales reorg seems to have paid off in 2009 as the company held the line on sales and marketing expenses despite a passel of global launches.
 
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Accountable Care Organizations Acquisition Adherence Advertising App Cardiovascular Clinical Trial Diabetes FDA Generic Generic Drugs Health Affairs Healthcare Reform Journal Articles Layoffs Mobile Obesity Oncology OPDP Patent Cliff Patents Research & Development Rheumatology Social Media Women's Health

Topics

Consumer
Continuing Medical Education (CME)
Digital
Direct to Consumer
Direct to Patient
Downsize
Education & Awareness
FDA
Label
Legal
Online
Over the Counter
Promotion
Public Relations
Sales Force
Trend

Sectors

Agency
Biotech
Government
Media
Pharmaceutical
Suppliers & Vendors

Verticals

Business
Marketing & Communications
Regulatory
Research & Development

Events

Awards

Archives

Issue Archive
Sitemap
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions